Minnesota to sue major insulin makers over price gouging, yet Merck walked from BioSimilar Lantus as it would not be profitable for them. Hopefully people will discover the real truth about drug prices soon.
@Diabetes_Sanofi My doctor refuses to return me to levels of pain meds that would help me exercise and work on reducing pre diabetic levels. Diabetes being 5 times more deadly than opioids doesn't seem to matter!
@DomLittlewood@dexcom@DiabetesUK I’m doing the same whilst injecting and finding my Lantus wearing off late afternoon between 5-8pm so have to do another jab of 3 units around 5ish annoyingly making it 5 jabs a day
The profits these companies made last year:
Novo Nordisk, manufacturer of Levemir: $6.07bn
Eli Lilly, manufacturer of Humalog: $1.77bn
Sanofi, manufacturer of Lantus: $3.24bn
(source FT.com market data) twitter.com/TimBlotzFOX9/s…
Attorney General Lori Swanson is suing 3 insulin makers for price gouging. She alleges that the makers of Levemir, Humalog and Lantus have artificially raised prices which makes them unaffordable for many of the estimated 450K Minnesotans with diabetes. @FOX9 at 6:30.
@Diabetes_Sanofi I ain't asking the doctor shit I can't afford my diabetes medication so I just go without which will probably kill me but that's the prime reason why healthcare in the US is so high to kill as many of us off as possible with drawing too much attention.
In other words it's designed to make you give up and save billions on legal fees. This keeps new competitors out of the drug market. And keeps insulin prices going up and up. See @Merck's decision to stop competing with Lantus insulin fiercepharma.com/pharma/merck-d…#insulin4all